Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer

PURPOSE. This double-blind, randomized, phase III clinical trial evaluated time to progression (TTP) and overall survival in women with metastatic breast cancer (MBC) who received sialyl-TN (STn) keyhole limpet hemocyanin (KLH) vaccine. Secondary endpoints included vaccine safety and immune response...

詳細記述

保存先:
書誌詳細
主要な著者: Miles, David, Roché, Henri, Martin, Miguel, Perren, Timothy J., Cameron, David A., Glaspy, John, Dodwell, David, Parker, Joanne, Mayordomo, José, Tres, Alejandro, Murray, James Lee, Ibrahim, Nuhad K.
フォーマット: Artigo
言語:Inglês
出版事項: AlphaMed Press 2011
主題:
Breast Cancer
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228158/
https://ncbi.nlm.nih.gov/pubmed/21572124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0307
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料